MedTrace Logo

Lab-on-a-chip Detection of Cervical Cancer Tumour Markers

NCT03380741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-12-21

No results posted yet for this study

Summary

This study aims to establish whether tumour markers measured from cytological samples can improve cervical cancer detection both prior to treatment and after treatment during follow up.

All patients with presumed early cervical cancer referred to the Gynaecological Oncology Unit at The Royal Marsden Hospital and patients previously surgically treated for early cervical cancer with a suspected recurrence will be invited to participate.

Women attending the Colposcopy Unit at St George's Hospital, with a normal cervix will be invited to participate.

An endovaginal receiver coil has been designed and developed at the Institute of Cancer Research and Royal Marsden NHS Foundation Trust for use at high field strengths (3T).

A cytology swab, similar to a smear test, will be used to collect a sample of cells to evaluate the presence of tumour markers.

The presence of tumour markers will be measured by a lab-on-a-chip and polymerase chain reaction (PCR) testing system.

Conditions

Interventions

DIAGNOSTIC_TEST

Tumour markers detection

Lab on a chip detection of tumour markers measured from vaginal/cervical cytology swab

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • St. George's NHS Foundation Trust

    collaborator UNKNOWN

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2019-09-30
Completion
2019-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380741 on ClinicalTrials.gov